| NCT00659295
| Observational Study to Evaluate the Safety of Levemir® in Diabetes | |
| NCT00665093
| Observational Study of Patients Using NovoMix® 30 or Levemir® for Treatment of Type 1 or Type 2 Diabetes | |
| NCT01542489
| Observational Study of the Predictability of Levemir® in Terms of Metabolic Control, Change of Body Weight and Hypos | |
| NCT01548248
| Efficacy and Safety of Levemir® Used as Basal Insulin | |
| NCT00698269
| An Observational Study of Efficacy and Safety of Modern Insulin in Diabetes Patients Switched From Anti-diabetic Treatment | |
| NCT00706017
| Observational Study to Evaluate the Safety of Levemir® in Diabetes | |
| NCT01545791
| Observational Study to Evaluate the Safety of Levemir® in Patients With Diabetes | |
| NCT00655044
| Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes | |
| NCT00873639
| Observational Study of Type 1 Diabetics Switching From Human Insulins to Modern Insulin Analogues | |
| NCT01542476
| The Impact of Initiating/Switching to Insulin Detemir on Emotional Well-being and Treatment Satisfaction | |
| NCT00738153
| An Observational Study on Efficacy and Safety in Subjects Using Levemir® for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes | |
| NCT00849342
| Observational Study on Levemir® in Obese Diabetic Patients | |